| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 保肝护肝药物(元) | - | - | - | 202,699,400.74 | 88,076,904.70 |
| 呼吸系统药物(元) | - | 29,610,336.05 | 28,037,950.15 | 3,092,057.19 | 1,572,878.01 |
| 抗乙肝病毒药物(元) | - | - | - | 121,682,100.06 | 59,059,553.04 |
| 男性健康产品(元) | - | 22,084,872.50 | - | 10,418,603.75 | -1,186,349.79 |
| 消化系统药物(元) | - | 11,215,142.14 | - | 18,881,922.26 | 9,526,290.10 |
| 心血管药物(元) | - | 48,697,319.42 | 22,560,526.93 | 35,572,196.34 | 14,504,252.71 |
| 抗新冠病毒药物(元) | - | - | - | 20,971,308.85 | - |
| 肝胆疾病药物(元) | 169,767,093.14 | 325,474,079.23 | 144,345,212.07 | - | - |
| 其他(元) | - | 4,375,924.43 | - | - | - |
| 营业成本(元) | |||||
| 保肝护肝药物(元) | - | - | - | 39,956,874.90 | 17,222,393.60 |
| 呼吸系统药物(元) | - | - | 13,651,550.51 | - | - |
| 抗乙肝病毒药物(元) | - | - | - | 70,492,855.43 | 33,896,299.26 |
| 男性健康产品(元) | - | - | - | - | - |
| 消化系统药物(元) | - | - | - | - | - |
| 心血管药物(元) | - | 17,444,486.04 | 7,089,806.86 | - | - |
| 抗新冠病毒药物(元) | - | - | - | - | - |
| 肝胆疾病药物(元) | 52,716,035.95 | 101,833,147.53 | 45,045,544.39 | - | - |
| 其他(元) | - | - | - | - | - |
| 毛利(元) | |||||
| 保肝护肝药物(元) | - | - | - | 162,742,525.84 | 70,854,511.10 |
| 呼吸系统药物(元) | - | - | 14,386,399.64 | - | - |
| 抗乙肝病毒药物(元) | - | - | - | 51,189,244.63 | 25,163,253.78 |
| 男性健康产品(元) | - | - | - | - | - |
| 消化系统药物(元) | - | - | - | - | - |
| 心血管药物(元) | - | 31,252,833.38 | 15,470,720.07 | - | - |
| 抗新冠病毒药物(元) | - | - | - | - | - |
| 肝胆疾病药物(元) | 117,051,057.19 | 223,640,931.70 | 99,299,667.68 | - | - |
| 其他(元) | - | - | - | - | - |
| 毛利率(%) | |||||
| 保肝护肝药物(%) | - | - | - | 80.29 | 80.45 |
| 呼吸系统药物(%) | - | - | 51.31 | - | - |
| 抗乙肝病毒药物(%) | - | - | - | 42.07 | 42.61 |
| 男性健康产品(%) | - | - | - | - | - |
| 消化系统药物(%) | - | - | - | - | - |
| 心血管药物(%) | - | 64.18 | 68.57 | - | - |
| 抗新冠病毒药物(%) | - | - | - | - | - |
| 肝胆疾病药物(%) | 68.95 | 68.71 | 68.79 | - | - |
| 其他(%) | - | - | - | - | - |
| 收入构成(%) | |||||
| 保肝护肝药物(%) | - | - | - | 49.04 | 51.34 |
| 呼吸系统药物(%) | - | 6.71 | 14.38 | 0.75 | 0.92 |
| 抗乙肝病毒药物(%) | - | - | - | 29.44 | 34.43 |
| 男性健康产品(%) | - | 5.00 | - | 2.52 | -0.69 |
| 消化系统药物(%) | - | 2.54 | - | 4.57 | 5.55 |
| 心血管药物(%) | - | 11.03 | 11.57 | 8.61 | 8.45 |
| 抗新冠病毒药物(%) | - | - | - | 5.07 | - |
| 肝胆疾病药物(%) | 100.00 | 73.73 | 74.04 | - | - |
| 其他(%) | - | 0.99 | - | - | - |
| 毛利构成(%) | |||||
| 保肝护肝药物(%) | - | - | - | 76.07 | 73.79 |
| 呼吸系统药物(%) | - | 0.00 | 11.14 | 0.00 | 0.00 |
| 抗乙肝病毒药物(%) | - | - | - | 23.93 | 26.21 |
| 男性健康产品(%) | - | 0.00 | - | 0.00 | 0.00 |
| 消化系统药物(%) | - | 0.00 | - | 0.00 | 0.00 |
| 心血管药物(%) | - | 12.26 | 11.98 | 0.00 | 0.00 |
| 抗新冠病毒药物(%) | - | - | - | 0.00 | - |
| 肝胆疾病药物(%) | 100.00 | 87.74 | 76.88 | - | - |
| 其他(%) | - | 0.00 | - | - | - |